Weimai Medical Funding: $284M Raised, Series D (2025)
Weimai Medical is based in Hangzhou, China. It has raised $284M in total funding. Latest round: Series D.
Weimai Medical funding overview
Weimai Medical is based in Hangzhou, China. Weimai Medical has raised $284M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series D announced in January 2025. The round record for Weimai Medical runs through 2025; nothing later has been disclosed. Investors on record include CNCB INVESTMENT, CHOICE CAPITAL, Yuhang Transformation Industry Investment, Deqing Industry Development Investment, Nanhu Investment, Source Code Capital and 2 others. 8 distinct backers are named across the disclosed rounds.
Weimai Medical at a glance
Total raised
$284M
Latest round
Series D
Latest round date
January 2025
Headquarters
Hangzhou, China
Notable investors
CNCB INVESTMENT, CHOICE CAPITAL, Yuhang Transformation Industry Investment, Deqing Industry Development Investment, Nanhu Investment, Source Code Capital, Cenova Ventures, Vision+ Capital
Frequently asked about Weimai Medical funding
How much has Weimai Medical raised?
Weimai Medical has raised $284M in total disclosed funding across the rounds on record.
Who has invested in Weimai Medical?
CNCB INVESTMENT, CHOICE CAPITAL, Yuhang Transformation Industry Investment, Deqing Industry Development Investment, Nanhu Investment, Source Code Capital are named among the investors backing Weimai Medical.
What was the latest Weimai Medical funding round?
The most recent disclosed round is a Series D, announced in January 2025.
Where is Weimai Medical based?
Weimai Medical is based in Hangzhou, China.
When did Weimai Medical last raise?
The last disclosed Weimai Medical round closed in January 2025 at Series D.
Round data for Weimai Medical is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Hangzhou and backer lists below.
